The human serum-based system shows reduced interferences when testing for pyrogenicity in more complex drug products, such as in blood-derived therapeutics
AstraZeneca also played a critical role in the global response to COVID-19.
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Subscribe To Our Newsletter & Stay Updated
